Cancer patient getting treatment (Photo: Shutterstock)

Access to specialty drugs through commercial health plans decreased from 2017 to 2021, and less than half of plans were consistent with FDA drug label indications, a recent study found. The National Pharmaceutical Council conducted the study in partnership with the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Cost-Containment
Employee Participation
Employer-Paid